The state of District Of Columbia currently has 2 active clinical trials seeking participants for Parkinson's Disease research studies. These trials are conducted in various cities, including Washington, Washington, D.C., Washington DC and Washington, Dc.
A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease
NCT05924243
Recruiting
This is a multi-center, randomized, double blind, adaptive, parallel-group, placebo controlled Phase 1b study to evaluate the safety, tolerability, pharmacokinetic (PK) and pharmacodynamics of RO7486967 in participants with idiopathic PD at the early stage of the disease (modified H&Y stage ≤2.5) who are either treatment-naïve or on stable treatment with symptomatic therapy (levodopa and/or pramipexole, ropinirole, rotigotine).
Gender:
All
Ages:
Between 40 years and 85 years
Trial Updated:
06/07/2024
Locations: Georgetown University, Washington, District of Columbia
Conditions: Parkinson Disease
Register for Updates
Social & QoL Behaviors in Parkinson's Disease
NCT06385184
Recruiting
Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (QoL) compared to people of the same age without Parkinson's Disease.
Gender:
All
Ages:
40 years and above
Trial Updated:
04/23/2024
Locations: The George Washington University, Washington, District of Columbia
Conditions: Parkinson Disease
Register for Updates